Journal article
Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical Trial
Abstract
IMPORTANCE: The Canadian Cancer Trials Group study HN.6 is the largest randomized clinical trial to date comparing the concurrent administration of anti-epidermal growth factor receptor (EGFR) monoclonal antibodies with radiotherapy (RT) to standard chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN).
OBJECTIVE: To compare progression-free survival (PFS) in patients with LA-SCCHN treated with …
Authors
Siu LL; Waldron JN; Chen BE; Winquist E; Wright JR; Nabid A; Hay JH; Ringash J; Liu G; Johnson A
Journal
JAMA Oncology, Vol. 3, No. 2, pp. 220–226
Publisher
American Medical Association (AMA)
Publication Date
February 1, 2017
DOI
10.1001/jamaoncol.2016.4510
ISSN
2374-2437